Evaluating the Effect of Treatment Persistence on the Economic Burden of Moderate to Severe Psoriasis and/or Psoriatic Arthritis Patients in the U.S. Department of Defense Population

BACKGROUND: Psoriasis is a chronic, hyper-proliferative dermatological condition associated with joint symptoms known as psoriatic arthritis (PsA). In a 2013 review, the total economic burden of PsA was estimated at $51.7-$63.2 billion. The economic burden of moderate to severe psoriasis patients ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seina, Xie, Lin, Wang, Yuexi, Vaidya, Neel, Baser, Onur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398301/
https://www.ncbi.nlm.nih.gov/pubmed/29952710
http://dx.doi.org/10.18553/jmcp.2018.24.7.654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398301/
https://www.ncbi.nlm.nih.gov/pubmed/29952710
http://dx.doi.org/10.18553/jmcp.2018.24.7.654

Ejemplares similares